发明授权
US09593069B2 Cyclohexane-1,3-diones for use in the treatment of amyotrophic lateral sclerosis
有权
用于治疗肌萎缩性侧索硬化症的环己烷-1,3-二酮
- 专利标题： Cyclohexane-1,3-diones for use in the treatment of amyotrophic lateral sclerosis
- 专利标题（中）： 用于治疗肌萎缩性侧索硬化症的环己烷-1,3-二酮
-
申请号： US14887550申请日： 2015-10-20
-
公开(公告)号： US09593069B2公开(公告)日： 2017-03-14
- 发明人: Donald R. Kirsch , Radhia Benmohamed , Anthony C. Arvanites , Richard I. Morimoto , Wei Zhang , Richard B. Silverman
- 申请人： Northwestern University , Cambria Pharmaceuticals, Inc.
- 申请人地址： US IL Evanston US MA Woburn
- 专利权人： Northwestern University,Cambria Pharmaceuticals, Inc.
- 当前专利权人： Northwestern University,Cambria Pharmaceuticals, Inc.
- 当前专利权人地址： US IL Evanston US MA Woburn
- 代理机构： Andrus Intellectual Property Law, LLP
- 主分类号： A61K31/00
- IPC分类号： A61K31/00 ; C07C69/75 ; A61K31/136 ; C07C49/563 ; C07C49/567 ; C07C49/577
摘要：
The present invention relates to the identification of provided cyclohexane-1,3-diones (CHD compounds) and pharmaceutical compositions thereof for treating subjects with amyotrophic lateral sclerosis (ALS) and other neurodegenerative diseases. The invention also provides methods of preparing the provided CHD compounds.
公开/授权文献
信息查询
